PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS

PHARMACOECONOMIC SUBSTANTIATION OF APPLICATION OF GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN OUT-PATIENT CONDITIONS

Objective. Carrying out of the comparative clinical and economic analysis of treatment of patients with rheumatic diseases (RD) by genetically engineered biological agents (GEBA) in conditions of round-the-clock and day-time in-patient departments.Materials and Methods. In a basis pharmacoeconomic c...

Full description

Saved in:
Bibliographic Details
Main Authors: O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina
Format: Article
Language:Russian
Published: IRBIS LLC 2016-04-01
Series:Фармакоэкономика
Subjects:
clinical and economic analysis
genetically engineered biological agents
hospitalization replacement technologies
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/135
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items